Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics

Jianliang Shen, Han Cheon Kim, Hua Su, Feng Wang, Joy Wolfram, Dickson Kirui, Junhua Mai, Chaofeng Mu, Liang Nian Ji, Zong Wan Mao, Haifa Shen

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Effective delivery holds the key to successful in vivo application of therapeutic small interfering RNA (siRNA). In this work, we have developed a universal siRNA carrier consisting of a mesoporous silica nanoparticle (MSNP) functionalized with cyclodextrin-grafted polyethylenimine (CP). CP provides positive charge for loading of siRNA through electrostatic interaction and enables effective endosomal escape of siRNA. Using intravital microscopy we were able to monitor tumor enrichment of CP-MSNP/siRNA particles in live mice bearing orthotopic MDA-MB-231 xenograft tumors. CP-MSNP delivery of siRNA targeting the M2 isoform of the glycolytic enzyme pyruvate kinase (PKM2) resulted in effective knockdown of gene expression in vitro and in vivo. Suppression of PKM2 led to inhibition of tumor cell growth, invasion, and migration.

Original languageEnglish (US)
Pages (from-to)487-497
Number of pages11
JournalTheranostics
Volume4
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Polyethyleneimine
Cyclodextrins
Silicon Dioxide
Nanoparticles
Small Interfering RNA
Neoplasms
Therapeutics
Pyruvate Kinase
Static Electricity
Heterografts
Protein Isoforms
Gene Expression
Enzymes
Growth

Keywords

  • Cancer therapy
  • Delivery
  • Gene silencing
  • Mesoporous silica nanoparticle
  • siRNA

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cite this

Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. / Shen, Jianliang; Kim, Han Cheon; Su, Hua; Wang, Feng; Wolfram, Joy; Kirui, Dickson; Mai, Junhua; Mu, Chaofeng; Ji, Liang Nian; Mao, Zong Wan; Shen, Haifa.

In: Theranostics, Vol. 4, No. 5, 2014, p. 487-497.

Research output: Contribution to journalArticle

Shen, J, Kim, HC, Su, H, Wang, F, Wolfram, J, Kirui, D, Mai, J, Mu, C, Ji, LN, Mao, ZW & Shen, H 2014, 'Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics', Theranostics, vol. 4, no. 5, pp. 487-497. https://doi.org/10.7150/thno.8263
Shen, Jianliang ; Kim, Han Cheon ; Su, Hua ; Wang, Feng ; Wolfram, Joy ; Kirui, Dickson ; Mai, Junhua ; Mu, Chaofeng ; Ji, Liang Nian ; Mao, Zong Wan ; Shen, Haifa. / Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. In: Theranostics. 2014 ; Vol. 4, No. 5. pp. 487-497.
@article{443bc848875c4d64b6b1425ecf25bf71,
title = "Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics",
abstract = "Effective delivery holds the key to successful in vivo application of therapeutic small interfering RNA (siRNA). In this work, we have developed a universal siRNA carrier consisting of a mesoporous silica nanoparticle (MSNP) functionalized with cyclodextrin-grafted polyethylenimine (CP). CP provides positive charge for loading of siRNA through electrostatic interaction and enables effective endosomal escape of siRNA. Using intravital microscopy we were able to monitor tumor enrichment of CP-MSNP/siRNA particles in live mice bearing orthotopic MDA-MB-231 xenograft tumors. CP-MSNP delivery of siRNA targeting the M2 isoform of the glycolytic enzyme pyruvate kinase (PKM2) resulted in effective knockdown of gene expression in vitro and in vivo. Suppression of PKM2 led to inhibition of tumor cell growth, invasion, and migration.",
keywords = "Cancer therapy, Delivery, Gene silencing, Mesoporous silica nanoparticle, siRNA",
author = "Jianliang Shen and Kim, {Han Cheon} and Hua Su and Feng Wang and Joy Wolfram and Dickson Kirui and Junhua Mai and Chaofeng Mu and Ji, {Liang Nian} and Mao, {Zong Wan} and Haifa Shen",
year = "2014",
doi = "10.7150/thno.8263",
language = "English (US)",
volume = "4",
pages = "487--497",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics

AU - Shen, Jianliang

AU - Kim, Han Cheon

AU - Su, Hua

AU - Wang, Feng

AU - Wolfram, Joy

AU - Kirui, Dickson

AU - Mai, Junhua

AU - Mu, Chaofeng

AU - Ji, Liang Nian

AU - Mao, Zong Wan

AU - Shen, Haifa

PY - 2014

Y1 - 2014

N2 - Effective delivery holds the key to successful in vivo application of therapeutic small interfering RNA (siRNA). In this work, we have developed a universal siRNA carrier consisting of a mesoporous silica nanoparticle (MSNP) functionalized with cyclodextrin-grafted polyethylenimine (CP). CP provides positive charge for loading of siRNA through electrostatic interaction and enables effective endosomal escape of siRNA. Using intravital microscopy we were able to monitor tumor enrichment of CP-MSNP/siRNA particles in live mice bearing orthotopic MDA-MB-231 xenograft tumors. CP-MSNP delivery of siRNA targeting the M2 isoform of the glycolytic enzyme pyruvate kinase (PKM2) resulted in effective knockdown of gene expression in vitro and in vivo. Suppression of PKM2 led to inhibition of tumor cell growth, invasion, and migration.

AB - Effective delivery holds the key to successful in vivo application of therapeutic small interfering RNA (siRNA). In this work, we have developed a universal siRNA carrier consisting of a mesoporous silica nanoparticle (MSNP) functionalized with cyclodextrin-grafted polyethylenimine (CP). CP provides positive charge for loading of siRNA through electrostatic interaction and enables effective endosomal escape of siRNA. Using intravital microscopy we were able to monitor tumor enrichment of CP-MSNP/siRNA particles in live mice bearing orthotopic MDA-MB-231 xenograft tumors. CP-MSNP delivery of siRNA targeting the M2 isoform of the glycolytic enzyme pyruvate kinase (PKM2) resulted in effective knockdown of gene expression in vitro and in vivo. Suppression of PKM2 led to inhibition of tumor cell growth, invasion, and migration.

KW - Cancer therapy

KW - Delivery

KW - Gene silencing

KW - Mesoporous silica nanoparticle

KW - siRNA

UR - http://www.scopus.com/inward/record.url?scp=84902494149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902494149&partnerID=8YFLogxK

U2 - 10.7150/thno.8263

DO - 10.7150/thno.8263

M3 - Article

C2 - 24672582

AN - SCOPUS:84902494149

VL - 4

SP - 487

EP - 497

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 5

ER -